Idioma original | English (US) |
---|---|
Páginas (desde-hasta) | 144-145 |
Número de páginas | 2 |
Publicación | Journal of Vascular and Interventional Radiology |
Volumen | 32 |
N.º | 1 |
DOI | |
Estado | Published - ene 2021 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine
Acceder al documento
Otros archivos y enlaces
Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
En: Journal of Vascular and Interventional Radiology, Vol. 32, N.º 1, 01.2021, p. 144-145.
Producción científica: Article › revisión exhaustiva
}
TY - JOUR
T1 - Society of Interventional Radiology Guidelines and Statements Division 2020 Midyear Document Review
AU - Schiro, Brian J.
AU - An, Thomas
AU - Walker, T. Gregory
AU - Gemmete, Joseph J.
AU - Angle, John F.
AU - Plotnik, Adam N.
AU - Suri, Rajeev
AU - Kalva, Sanjeeva P.
AU - Dowell, Joshua
AU - Moriarty, John
N1 - Funding Information: B.J.S. receives personal fees from Penumbra (Alameda, California), Medtronic (Dublin, Ireland), and Sirtex (Boston, Massachusetts) and research grants from Medtronic. J.F.A. receives grants from Siemens (Erlangen, Germany) and Endoron (Kfar Saba, Israel). S.P.K. receives royalties from Springer (New York, New York) and Elsevier (Amsterdam, The Netherlands), consulting fees from Dova Pharmaceuticals (Durham, North Carolina), Boston Scientific (Marlborough, Massachusetts), Medtronic, Penumbra, and GE Healthcare (Chicago, Illinois), and research grants from BD (Franklin Lakes, New Jersey), and is an investor in AltheaHealth (San Francisco, California). S.P.K. also acknowledges funding from the Koo Foundation and the National Institutes of Health. J.M. receives grants from AngioDynamics (Latham, New York) and Penumbra and personal fees from Argon Medical (Ft. Worth, Texas), BD Bard (Covington, Georgia), and Thrombolex (New Britain, Pennsylvania). None of the other authors have reported a conflict of interest. Funding Information: B.J.S. receives personal fees from Penumbra (Alameda, California), Medtronic (Dublin, Ireland), and Sirtex (Boston, Massachusetts) and research grants from Medtronic . J.F.A. receives grants from Siemens (Erlangen, Germany) and Endoron (Kfar Saba, Israel). S.P.K. receives royalties from Springer (New York, New York) and Elsevier (Amsterdam, The Netherlands), consulting fees from Dova Pharmaceuticals (Durham, North Carolina), Boston Scientific (Marlborough, Massachusetts), Medtronic, Penumbra, and GE Healthcare (Chicago, Illinois), and research grants from BD (Franklin Lakes, New Jersey), and is an investor in AltheaHealth (San Francisco, California). S.P.K. also acknowledges funding from the Koo Foundation and the National Institutes of Health . J.M. receives grants from AngioDynamics (Latham, New York) and Penumbra and personal fees from Argon Medical (Ft. Worth, Texas), BD Bard (Covington, Georgia), and Thrombolex (New Britain, Pennsylvania). None of the other authors have reported a conflict of interest.
PY - 2021/1
Y1 - 2021/1
UR - http://www.scopus.com/inward/record.url?scp=85098203907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098203907&partnerID=8YFLogxK
U2 - 10.1016/j.jvir.2020.09.001
DO - 10.1016/j.jvir.2020.09.001
M3 - Article
C2 - 33388107
AN - SCOPUS:85098203907
SN - 1051-0443
VL - 32
SP - 144
EP - 145
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
IS - 1
ER -